Search Icon

Resources

Find up-to-date information on generics and biosimilars

  • Reset
  • Press Releases

AAM Comments on Medicare Drug Price Negotiation List
  • Press Releases

AAM Applauds Senate Bill to Protect Patient Access to Affordable Medicines
  • Press Releases

AAM Comments on End of Year Funding Bill
  • Blog

Congress Should Pass Legislation to End the Shenanigans That Allow Brand-Name Drug Manufacturers to Delay Generic Competition and Charge Higher Prices for Longer Periods
  • Press Releases

Medicare Plans Continue Trend of Restricting Generic Drugs
  • Blog

GRx+Biosims 2024 Conference Recap
  • Press Releases

AAM & Biosimilars Council Statement on Presidential Election
  • Press Releases

$2 Generics List Not the Solution
  • Press Releases

John Murphy Named President and CEO of AAM
  • Press Releases

40 Years of Hatch-Waxman – Trillions in Savings for Patients
  • Press Releases

AAM Urges Congress to Pass Key Bills Considered by the Senate HELP Committee This Week
  • Press Releases

Generic Medicines Increase Patient Access More Than Government Negotiated Price Controls
Load More

Generics

are a proven prescription for a healthier society.

Generic and biosimilar medicines make it easier and more affordable for patients to live healthier lives.

Learn More
Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington DC 20001
JOIN

Advocacy

About Us

Events

Resources

Sign-up for Update

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Subscribe
© 2025 Association for Accessible Medicines (AAM), All Rights Reserved Privacy Policy  |  Terms of Use  |  Contact

Stay Connected

For the latest updates, follow us on social media.

Facebook-f X-twitter Linkedin-in Youtube Instagram